{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T19:56:19Z","timestamp":1778270179794,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T00:00:00Z","timestamp":1523404800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00392-018-1246-y","type":"journal-article","created":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T06:27:18Z","timestamp":1523428038000},"page":"788-798","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Patent foramen ovale closure versus medical therapy for prevention of recurrent cryptogenic embolism: updated meta-analysis of randomized clinical trials"],"prefix":"10.1007","volume":"107","author":[{"given":"Brunilda","family":"Alushi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Lauten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Cassese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roisin","family":"Colleran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Sch\u00fcpke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Himanshu","family":"Rai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heribert","family":"Schunkert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Meier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"Landmesser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adnan","family":"Kastrati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,11]]},"reference":[{"issue":"4","key":"1246_CR1","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/ana.410250410","volume":"25","author":"RL Sacco","year":"1989","unstructured":"Sacco RL, Ellenberg JH, Mohr JP, Tatemichi TK, Hier DB, Price TR, Wolf PA (1989) Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol 25 (4):382\u2013390. \n                    https:\/\/doi.org\/10.1002\/ana.410250410","journal-title":"Ann Neurol"},{"issue":"3","key":"1246_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000047697","volume":"12","author":"BI Lee","year":"2001","unstructured":"Lee BI, Nam HS, Heo JH, Kim DI, Yonsei Stroke T (2001) Yonsei Stroke Registry. Analysis of 1,000 patients with acute cerebral infarctions. Cerebrovasc Dis 12 (3):145\u2013151. \n                    https:\/\/doi.org\/10.1159\/000047697","journal-title":"Cerebrovasc Dis"},{"issue":"6","key":"1246_CR3","first-page":"847","volume":"82","author":"P Lechat","year":"1989","unstructured":"Lechat P, Lascault G, Mas JL, Loron P, Klimczac K, Guggiari M, Drobinski G, Fraysse JB, Thomas D, Grosgogeat Y (1989) Prevalence of patent foramen ovale in young patients with ischemic cerebral complications. Arch Mal Coeur Vaiss 82 (6):847\u2013852","journal-title":"Arch Mal Coeur Vaiss"},{"key":"1246_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1476-7120-7-15","volume":"7","author":"F Knebel","year":"2009","unstructured":"Knebel F, Masuhr F, von Hausen W, Walde T, Dreger H, Raab V, Yuerek M, Baumann G, Borges AC (2009) Transesophageal echocardiography in patients with cryptogenic cerebral ischemia. Cardiovasc Ultrasound 7:15. \n                    https:\/\/doi.org\/10.1186\/1476-7120-7-15","journal-title":"Cardiovasc Ultrasound"},{"issue":"6","key":"1246_CR5","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1161\/CIRCULATIONAHA.111.030494","volume":"125","author":"A Wahl","year":"2012","unstructured":"Wahl A, Juni P, Mono ML, Kalesan B, Praz F, Geister L, Raber L, Nedeltchev K, Mattle HP, Windecker S, Meier B (2012) Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism. Circulation 125 (6):803\u2013812. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.030494","journal-title":"Circulation"},{"issue":"11","key":"1246_CR6","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.4244\/EIJV9I11A225","volume":"9","author":"D Capodanno","year":"2014","unstructured":"Capodanno D, Milazzo G, Vitale L, Di Stefano D, Di Salvo M, Grasso C, Tamburino C (2014) Updating the evidence on patent foramen ovale closure versus medical therapy in patients with cryptogenic stroke: a systematic review and comprehensive meta-analysis of 2,303 patients from three randomised trials and 2,231 patients from 11 observational studies. EuroIntervention 9 (11):1342\u20131349. \n                    https:\/\/doi.org\/10.4244\/EIJV9I11A225","journal-title":"EuroIntervention"},{"issue":"2","key":"1246_CR7","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/eurheartj\/ehu292","volume":"36","author":"S Stortecky","year":"2015","unstructured":"Stortecky S, da Costa BR, Mattle HP, Carroll J, Hornung M, Sievert H, Trelle S, Windecker S, Meier B, Juni P (2015) Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: a network meta-analysis. Eur Heart J 36 (2):120\u2013128. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehu292","journal-title":"Eur Heart J"},{"issue":"8","key":"1246_CR8","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.jacc.2015.12.023","volume":"67","author":"DM Kent","year":"2016","unstructured":"Kent DM, Dahabreh IJ, Ruthazer R, Furlan AJ, Reisman M, Carroll JD, Saver JL, Smalling RW, Juni P, Mattle HP, Meier B, Thaler DE (2016) Device closure of patent foramen ovale after stroke: pooled analysis of completed randomized trials. J Am Coll Cardiol 67 (8):907\u2013917. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2015.12.023","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"1246_CR9","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1056\/NEJMoa1009639","volume":"366","author":"AJ Furlan","year":"2012","unstructured":"Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW, Felberg R, Herrmann H, Kar S, Landzberg M, Raizner A, Wechsler L, Investigators CI (2012) Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med 366 (11):991\u2013999. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1009639","journal-title":"N Engl J Med"},{"issue":"12","key":"1246_CR10","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","volume":"368","author":"B Meier","year":"2013","unstructured":"Meier B, Kalesan B, Mattle HP, Khattab AA, Hildick-Smith D, Dudek D, Andersen G, Ibrahim R, Schuler G, Walton AS, Wahl A, Windecker S, Juni P, Investigators PCT (2013) Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med 368 (12):1083\u20131091. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1211716","journal-title":"N Engl J Med"},{"issue":"12","key":"1246_CR11","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1056\/NEJMoa1301440","volume":"368","author":"JD Carroll","year":"2013","unstructured":"Carroll JD, Saver JL, Thaler DE, Smalling RW, Berry S, MacDonald LA, Marks DS, Tirschwell DL, Investigators R (2013) Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med 368 (12):1092\u20131100. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1301440","journal-title":"N Engl J Med"},{"issue":"11","key":"1246_CR12","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","volume":"377","author":"JL Mas","year":"2017","unstructured":"Mas JL, Derumeaux G, Guillon B, Massardier E, Hosseini H, Mechtouff L, Arquizan C, Bejot Y, Vuillier F, Detante O, Guidoux C, Canaple S, Vaduva C, Dequatre-Ponchelle N, Sibon I, Garnier P, Ferrier A, Timsit S, Robinet-Borgomano E, Sablot D, Lacour JC, Zuber M, Favrole P, Pinel JF, Apoil M, Reiner P, Lefebvre C, Guerin P, Piot C, Rossi R, Dubois-Rande JL, Eicher JC, Meneveau N, Lusson JR, Bertrand B, Schleich JM, Godart F, Thambo JB, Leborgne L, Michel P, Pierard L, Turc G, Barthelet M, Charles-Nelson A, Weimar C, Moulin T, Juliard JM, Chatellier G, Investigators C (2017) Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N Engl J Med 377 (11):1011\u20131021. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1705915","journal-title":"N Engl J Med"},{"issue":"11","key":"1246_CR13","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","volume":"377","author":"JL Saver","year":"2017","unstructured":"Saver JL, Carroll JD, Thaler DE, Smalling RW, MacDonald LA, Marks DS, Tirschwell DL, Investigators R (2017) Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med 377 (11):1022\u20131032. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1610057","journal-title":"N Engl J Med"},{"issue":"11","key":"1246_CR14","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","volume":"377","author":"L Sondergaard","year":"2017","unstructured":"Sondergaard L, Kasner SE, Rhodes JF, Andersen G, Iversen HK, Nielsen-Kudsk JE, Settergren M, Sjostrand C, Roine RO, Hildick-Smith D, Spence JD, Thomassen L, Gore RCSI (2017) Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med 377 (11):1033\u20131042. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1707404","journal-title":"N Engl J Med"},{"issue":"7414","key":"1246_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327 (7414):557\u2013560. \n                    https:\/\/doi.org\/10.1136\/bmj.327.7414.557","journal-title":"BMJ"},{"issue":"11","key":"1246_CR16","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1001\/jama.282.11.1054","volume":"282","author":"P Juni","year":"1999","unstructured":"Juni P, Witschi A, Bloch R, Egger M (1999) The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 282 (11):1054\u20131060","journal-title":"JAMA"},{"issue":"1","key":"1246_CR17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/sim.2528","volume":"26","author":"MJ Bradburn","year":"2007","unstructured":"Bradburn MJ, Deeks JJ, Berlin JA, Russell Localio A (2007) Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events. Stat Med 26 (1):53\u201377. \n                    https:\/\/doi.org\/10.1002\/sim.2528","journal-title":"Stat Med"},{"issue":"3","key":"1246_CR18","doi-asserted-by":"publisher","first-page":"e59202","DOI":"10.1371\/journal.pone.0059202","volume":"8","author":"RM Turner","year":"2013","unstructured":"Turner RM, Bird SM, Higgins JP (2013) The impact of study size on meta-analyses: examination of underpowered studies in Cochrane reviews. PLoS One 8 (3):e59202. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0059202","journal-title":"PLoS One"},{"key":"1246_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-2-1","volume":"2","author":"CJ Cates","year":"2002","unstructured":"Cates CJ (2002) Simpson\u2019s paradox and calculation of number needed to treat from meta-analysis. BMC Med Res Methodol 2:1","journal-title":"BMC Med Res Methodol"},{"issue":"7197","key":"1246_CR20","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1136\/bmj.318.7197.1548","volume":"318","author":"L Smeeth","year":"1999","unstructured":"Smeeth L, Haines A, Ebrahim S (1999) Numbers needed to treat derived from meta-analyses\u2013sometimes informative, usually misleading. BMJ 318 (7197):1548\u20131551","journal-title":"BMJ"},{"issue":"7","key":"1246_CR21","doi-asserted-by":"publisher","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","volume":"6","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6 (7):e1000100. \n                    https:\/\/doi.org\/10.1371\/journal.pmed.1000100","journal-title":"PLoS Med"},{"issue":"2","key":"1246_CR22","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1161\/01.STR.0000199147.30016.74","volume":"37","author":"RL Sacco","year":"2006","unstructured":"Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P, Halperin J, Harbaugh R, Johnston SC, Katzan I, Kelly-Hayes M, Kenton EJ, Marks M, Schwamm LH, Tomsick T, American Heart A, American Stroke Association Council on S, Council on Cardiovascular R, Intervention, American Academy of N (2006) Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association\/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 37 (2):577\u2013617. \n                    https:\/\/doi.org\/10.1161\/01.STR.0000199147.30016.74","journal-title":"Stroke"},{"issue":"1","key":"1246_CR23","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.amjcard.2008.08.036","volume":"103","author":"SS Goel","year":"2009","unstructured":"Goel SS, Tuzcu EM, Shishehbor MH, de Oliveira EI, Borek PP, Krasuski RA, Rodriguez LL, Kapadia SR (2009) Morphology of the patent foramen ovale in asymptomatic versus symptomatic (stroke or transient ischemic attack) patients. Am J Cardiol 103 (1):124\u2013129. \n                    https:\/\/doi.org\/10.1016\/j.amjcard.2008.08.036","journal-title":"Am J Cardiol"},{"issue":"22","key":"1246_CR24","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1161\/01.CIR.0000017498.88393.44","volume":"105","author":"S Homma","year":"2002","unstructured":"Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP, Investigators PFOiCSS (2002) Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation 105 (22):2625\u20132631","journal-title":"Circulation"},{"issue":"3","key":"1246_CR25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1053\/euhj.2001.2293","volume":"22","author":"AV Mattioli","year":"2001","unstructured":"Mattioli AV, Aquilina M, Oldani A, Longhini C, Mattioli G (2001) Atrial septal aneurysm as a cardioembolic source in adult patients with stroke and normal carotid arteries. A multicentre study. Eur Heart J 22 (3):261\u2013268. \n                    https:\/\/doi.org\/10.1053\/euhj.2001.2293","journal-title":"Eur Heart J"},{"issue":"10","key":"1246_CR26","doi-asserted-by":"publisher","first-page":"761","DOI":"10.2459\/JCM.0000000000000138","volume":"15","author":"B Alushi","year":"2014","unstructured":"Alushi B, Biasco L, Orzan F, Omede P, Sciuto F, Moretti C, Belli R, Defilippi G, Barisone G, Cerrato P, Gaita F (2014) Patent foramen ovale treatment strategy: an Italian large prospective study. J Cardiovasc Med (Hagerstown) 15 (10):761\u2013768. \n                    https:\/\/doi.org\/10.2459\/JCM.0000000000000138","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"1","key":"1246_CR27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1161\/CIRCIMAGING.113.000807","volume":"7","author":"BS Wessler","year":"2014","unstructured":"Wessler BS, Thaler DE, Ruthazer R, Weimar C, Di Tullio MR, Elkind MS, Homma S, Lutz JS, Mas JL, Mattle HP, Meier B, Nedeltchev K, Papetti F, Di Angelantonio E, Reisman M, Serena J, Kent DM (2014) Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database. Circ Cardiovasc Imaging 7 (1):125\u2013131. \n                    https:\/\/doi.org\/10.1161\/CIRCIMAGING.113.000807","journal-title":"Circ Cardiovasc Imaging"},{"key":"1246_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy121","author":"Y Ahmad","year":"2018","unstructured":"Ahmad Y, Howard JP, Arnold A, Shin MS, Cook C, Petraco R, Demir O, Williams L, Iglesias JF, Sutaria N, Malik I, Davies J, Mayet J, Francis D, Sen S (2018) Patent foramen ovale closure vs. medical therapy for cryptogenic stroke: a meta-analysis of randomized controlled trials. Eur Heart J. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehy121","journal-title":"Eur Heart J"},{"key":"1246_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2017.11.037","author":"T Ando","year":"2017","unstructured":"Ando T, Holmes AA, Pahuja M, Javed A, Briasoulis A, Telila T, Takagi H, Schreiber T, Afonso L, Grines CL, Bangalore S (2017) Meta-analysis comparing patent foramen ovale closure versus medical therapy to prevent recurrent cryptogenic stroke. Am J Cardiol. \n                    https:\/\/doi.org\/10.1016\/j.amjcard.2017.11.037","journal-title":"Am J Cardiol"},{"key":"1246_CR30","doi-asserted-by":"publisher","DOI":"10.7326\/m17-3033","author":"S Rosa De","year":"2018","unstructured":"De Rosa S, Sievert H, Sabatino J, Polimeni A, Sorrentino S, Indolfi C (2018) Percutaneous closure versus medical treatment in stroke patients with patent foramen ovale: a systematic review and meta-analysis. Ann Intern Med. \n                    https:\/\/doi.org\/10.7326\/m17-3033","journal-title":"Ann Intern Med"},{"key":"1246_CR31","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.117.020030","author":"G Ntaios","year":"2018","unstructured":"Ntaios G, Papavasileiou V, Sagris D, Makaritsis K, Vemmos K, Steiner T, Michel P (2018) Closure of patent foramen ovale versus medical therapy in patients with cryptogenic stroke or transient ischemic attack: updated systematic review and meta-analysis. Stroke. \n                    https:\/\/doi.org\/10.1161\/strokeaha.117.020030","journal-title":"Stroke"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00392-018-1246-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-018-1246-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-018-1246-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T23:12:06Z","timestamp":1554937926000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00392-018-1246-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,11]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["1246"],"URL":"https:\/\/doi.org\/10.1007\/s00392-018-1246-y","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,11]]},"assertion":[{"value":"25 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Colleran reports a grant from the Irish Board for Training in Cardiovascular Medicine sponsored by MSD, outside the submitted work. Prof. Lauten reports grants from Edwards Lifesciences, grants from Abbott Vascular, outside the submitted work. Prof. Meier was principal investigator of the PC trial and reports personal fees from Abbott, during the conduction of the study and Co-primary investigator of the PC trial (more than 2\u00a0years ago). Prof. Landmesser reports grants from Edwards Lifesciences, grants and personal fees from Abbott, outside the submitted work. All other authors report no relationships relevant to the contents of this paper to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}